635-65-4; 57-88-5; 60-27-5; 9007-49-2; age differences; albumins; bilirubin; cholesterol; clinical aspects; creatinine; diagnosis; DNA; encephalopathy; haemoglobin; haemorrhage; hepatitis B; hospital admission; hospitals; human diseases; intestines; leukocytes; liver; liver diseases; liver failure; men; mortality; patients; platelet count; retrospective studies; surgery; surgical operations; transplantation; treatment outcomes; viral hepatitis; viral diseases; Hepatitis B virus; man; Severe acute respiratory syndrome coronavirus 2; Beijing; China; Northern China; APEC countries; East Asia; Asia; high Human Development Index countries; upper-middle income countries; Orthohepadnavirus; Hepadnaviridae; DNA Reverse Transcribing Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; hepatic encephalopathy; Peking; People's Republic of China; clinical picture; deoxyribonucleic acid; hemoglobin; bleeding; hemorrhage; leucocytes; white blood cells; death rate; SARS-CoV-2; viral infections